The Real Downsides of Weight Loss Injections

What side effects do most people actually experience?

The most documented downside of weight loss injections is GI upset. Nausea tops the list, followed closely by vomiting, loose stools, constipation, and persistent burping. Reflux and indigestion are common too. For most people these are worst in the first two to four weeks, or in the days after a dose step-up, then they ease as the body adjusts. Fatigue and headaches are also reported, though less often.

A smaller group experiences more significant symptoms. Severe, persistent stomach pain that radiates toward the back is the key warning sign for acute pancreatitis, a known but infrequent risk the MHRA highlighted in a January 2026 Drug Safety Update covering GLP-1 medicines. That level of pain warrants urgent medical attention, not a wait-and-see. Gallbladder problems, injection-site reactions, and dizziness round out the less common but real concerns.

If you want to understand what the side effects of weight loss injections actually involve, including which symptoms tend to settle on their own and which need a call to your prescriber, our dedicated guide covers it in detail. For an honest look at the more serious end of the spectrum, the guide to serious side effects is worth reading before you start.

Is the injection itself a problem for most people?

For many, the idea of a weekly injection is the first obstacle. In practice, Mounjaro and Wegovy both use pre-filled pens with fine needles; the injections go into fatty tissue on the abdomen, thigh, or upper arm, and most people describe the sensation as minimal. The barrier tends to be psychological rather than physical, and it usually shrinks after the first or second injection.

That said, injection technique does matter. Rotating sites properly, using a fresh needle each time, and keeping the pen stored correctly are all part of safe use. Our replacement needles are available if you need them between supplies. The time commitment of once-weekly dosing is genuinely low compared to daily oral medicines, but the ongoing nature of treatment is worth acknowledging: stopping generally means weight returns, often within months, which is a documented pattern from trials and a real consideration when weighing up whether to start.

What are the practical and financial downsides?

Cost is one of the most tangible downsides to weight loss injections on a private basis. Eli Lilly raised Mounjaro's UK list price in September 2025, and since then typical private prices have ranged roughly £149 to £375 per month depending on dose and provider. That is not a small outgoing, and it is ongoing rather than one-off. You can see how weight loss injection prices break down across doses and what legitimate costs typically include.

Beyond cost, access through unverified channels carries a risk that deserves plain language. The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. Counterfeit pens have been found to contain insulin, causing serious harm. The safe route is a prescription from a registered prescriber, dispensed by a pharmacy you can verify on the GPhC register. Any seller offering these medicines without a prescription is a red flag, full stop.

There are also medicines-related interactions to factor in. Women using oral contraceptives who start tirzepatide should add a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced. That is a practical consideration that some people are not told about before they begin. Our FAQs cover several of these real-life questions if you want to read further.

Who genuinely should not use weight loss injections?

Certain groups are clearly outside what these medicines are licensed or recommended for. Under-18s are excluded. Anyone who is pregnant, breastfeeding, or actively trying to conceive is advised against using them; contraception guidance and a wash-out period before conception apply and should be discussed with a prescriber. A personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2 (MEN2), are contraindications. A history of pancreatitis, or certain gastrointestinal conditions, also require careful prescriber discussion before starting.

Even within eligible groups, BMI alone does not determine suitability. The prescriber looks at the whole picture: existing conditions, other medicines, and the realistic benefit-to-risk balance for that individual. That clinical judgement is the part that cannot be replicated by a simple online checkout. Our guide to the side effects of weight loss injections is one useful part of that broader picture, and if you want to go deeper on what those effects can look like day to day, our detailed look at the side effect of weight loss injections covers individual experiences in more depth, alongside our main guide on how these medicines are used in weight management. If you want to explore whether treatment could be appropriate for your situation, a free consultation with our prescribers is the right starting point, no obligation, and reviewed the same day by a real clinician.